... Email Notifications. See past imports to Inmunochemsac, an importer based in Peru. (Credit: Google Street View) Dutch medical testing company Qiagen… Qiagen NV QGEN, +0.70% shares rose in the extended session Wednesday after the Netherlands-based medical diagnostics company said it will begin selling a … Qiagen’s U.S. headquarters and research and development manufacturing facility is in Germantown, Maryland. ... by email … ET on TipRanks.com Qiagen (QGEN) was Upgraded to a Buy Rating at Kepler Capital QIAGEN (QGEN) Alert: Johnson Fistel Launches Investigation into QIAGEN N.V.; Investors Encouraged to Contact Firm ... by email or phone at 619-814-4471. If … Qiagen, an international life sciences company that provides molecular sample and assay technologies, is expanding its United States headquarters in Germantown to … Jul. Government Customs Records Notifications available for Qiagen. Get free access to all content including webinars, science talks and more; Receive email notifications about new content to keep you up-to-date; Join events and meet with the QIAGEN Cancer Research Community Fiscal 2020 has turned out to be one the best years for billionaire Izzy Englander's Millennium Management since 2000 as the multi-strategy hedge fund gained 23.3% through Dec. 17. Two analysts have made estimates for QIAGEN's earnings, with the highest sales estimate coming in … By using this site you agree to the use of cookies for analytics, personalized content and ads. Why register for My QIAGEN? QIAGEN (QGEN) Alert: Johnson Fistel Launches Investigation into QIAGEN N.V.; Investors Encouraged to Contact Firm News provided by. Status. Get today's Qiagen NV stock price and latest QIA news as well as Qiagen real-time stock quotes, technical analysis, full financials and more. Qiagen Lifts 2020, 2021 Outlook On Covid-19 Test Demand; Shares Rise Dec. 8, 2020 at 8:05 a.m. Wall Street brokerages forecast that QIAGEN (NYSE:QGEN) will post sales of $551.85 million for the current quarter, according to Zacks Investment Research. 23, 2012- Illumina, Inc. (NASDAQ: ILMN) today announced that the company has sought leave to file counterclaims against Intelligent Bio-Systems, Inc. (IBS) and Qiagen NV , which recently acquired IBS, in response to the patent lawsuit brought by Columbia University and IBS on March 26, 2012 in U.S. District Court in Wilmington, Delaware . Follow future shipping activity from Qiagen. Learn more